Notch1 signaling related hippocampal neurogenesis in adult poststroke depression rats: A valid index for an efficient combined citalopram and WAY100635 pharmacotherapy

Behavioural Pharmacology

Volumn 21, Issue 1, 2010, Pages 47-57

  Wang, Shao Hua ^a   Zhang, Zhi Jun ^a   Guo, Yi Jing ^a   Sui, Yu Xiu ^b   Sun, Yi ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Citalopram; Depressive; Hippocampus; Notch; Stroke; WAY100635

Indexed keywords

BROXURIDINE; CITALOPRAM; LIGAND; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NOTCH1 RECEPTOR; SEROTONIN 1A ANTAGONIST; SUCROSE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CHRONIC STRESS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION; GENE TARGETING; HIPPOCAMPUS; HYPOTHESIS; MALE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; RAT; SIGNAL TRANSDUCTION; STROKE;

ANIMALS; BEHAVIOR, ANIMAL; CITALOPRAM; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; GENE EXPRESSION; HIPPOCAMPUS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROGENESIS; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NOTCH1; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 74549158287     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e328334b677     Document Type: Article

References (53)

1. Abrous DN, Koehl M, Le Moal M (2005). Adult neurogenesis: from precursors to network and physiology. Physiol Rev 85:523-569.
2. Anderson GM, Barr CS, Lindell S, Durham AC, Shifrovich I, Higley JD (2005). Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey. Psychopharmacology 178:339-346.
3. Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin R, Poser SW, et al. (2006). Notch signaling regulates stem cell numbers in vitro and in vivo. Nature 442:823-826.
4. Arborelius L, Nomikos GG, Grillner P, Hertel P, Backlund Höök B, Hacksell U, et al. (1995). 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rat treated acutely or chronically with citalopram. Naunyn-Schmiedeberg's Arch Pharmacol 352:157-165.
5. Artigas F, Perez V, Alvarez E (1994). Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51:248-251.
6. Artigas F, Adell A, Celada P (2006). Pindolol augmentation of antidepressant response. Curr Drug Targets 7:139-147.
7. Azmitia BC, Whitaker-Azmitia PM (1997). Development and adult plasticity of serotoninergic nevirons and their target cells. In: Baumgarten HG, Gothert M, editors. Handbook of experimental pharmacology. Berlin: Springer. pp. 1-39.
8. Berman RM, Darnell AM, Miller HL, Anand A, Charney DS (1997). Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebocontrolled trial. Am J Psychiatry 154:37-43.
9. Berman RM, Anand A, Cappiello A, Miller HL, Hu XS, Oren DA, et al. (1999). The use of pindolol with fluoxetine in the treatment of major depression: final results from a doubleblind, placebo-controlled trial. Biol Psychiatry 45:1170-1177.
10. Bingham B, Liu D, Wood A, Cho S (2005). Ischemia-stimulated neurogenesis is regulated by proliferation, migration, differentiation and caspase activation of hippocampal precursor cells. Brain Res 1058:167-177.
11. Blier P, Bergeron R (1995). Effectiveness of pindolol with selected antidepres-sant drugs in the treatment of major depression. J Clin Psychopharmacol 15:217-222.
12. Blier P, de Montigny C, Chaput Y (1987). Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 7:24S-35S.
13. Bondolfi L, Ermini F, Long JM, Ingram DK, Jucker M (2004). Impact of age and caloric restriction on neurogenesis in the dentate gyrus of C57BL/6 mice. Neurobiol Aging 25:333-340.
14. Bordet R, Thomas P, Dupuis B (1998). Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Am J Psychiatry 155:1346-1351.
15. Chiba S (2006). Notch signaling in stem cell systems. Stem Cells 24:2437-2447.
16. Dawson LA, Nguyen HQ (1998). Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex. Eur J Pharmacol 345:41-46.
17. Dawson LA, Nguyen HQ (2000). The role of 5-HT (1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (±)pindolol. Neuropharmacology 39:1044-1052.
18. Fanburg BL, Lee SL (1997). A new role for an old molecule: serotonin as a mitogen. Am J Physiol 16:795-806.
19. Gartside SE, Umbers V, Hajos M, Sharp T (1995). Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol 115:1064-1070.
20. Grandbarbe L, Bouissac J, Rand M, Hrabé de Angelis M, Artavanis-Tsakonas S, Mohier E (2003). Delta-Notch signaling controls the generation of neurons/glia from neural stem cells in a stepwise process. Development 130:1391-1402.
21. Guo YJ, Zhang ZJ, Wang SH, Sui YX, Sun Y (2009). Notch1 signaling, hippocampal neurogenesis and behavioral responses to chronic unpredicted mild stress in adult ischemic rats. Prog Neuro-Psychoph 33:688-694.
22. Hackett ML, Yapa C, Parag V, Anderson CS (2005). Frequency of depression after stroke: a systematic review of observational studies. Stroke 36:1330-1340.
23. Hjorth S (1996). (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-HT. Eur J Pharmacol 303:183-186.
24. Hjorth S, Auerbach SB (1996). 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Behav Brain Res 73:281-283.
25. Hjorth S, Westlin D, Bengtsson HJ (1997). WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto) receptor blocker versus that of the 5-HT reuptake inhibitor. Neuropharmacology 36:461-465.
26. Jacobs BL (2002). Adult brain neurogenesis and depression. Brain Behav Immun 16:602-609.
27. Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, et al. (1994). Central pre-and postsynaptic 5-HT1A receptors in rats treated chronically with a the novel antidepressant, cericlamine. J Pharmacol Exp Ther 268:1432-1443.
28. Kawai T, Takagi N, Nakahara M, Takeo S (2005). Changes in the expression of Hes5 and Mash1 mRNA in the adult rat dentate gyrus after transient forebrain ischemia. Neurosci Lett 380:17-20.
29. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G (1986). Experimental studies of ischemic brain edema: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 8:1-8.
30. Kuhn HG, Dickinson-Anson H, Gage FH (1996). Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16:2027-2033.
31. Lasky JL, Wu H (2005). Notch signaling, brain development, and human disease. Pediatr Res 57:104-109.
32. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2[-delta delta C (T)] method. Methods 25:402-408.
33. Lledo PM, Alonso M, Grubb MS (2006). Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci 7:179-193.
34. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91.
35. López JF, Chalmers DT, Little KY, Watson SJ (1998). Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43:547-573.
36. Maes M, Libbrecht I, van Hunsel F, Campens D, Meltzer HY (1999). Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. J Clin Psychopharm 19:177-182.
37. Mann JJ (1999). Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21:99S-105S.
38. Paxinos G, Watson C (1997). The rat brain in stereotaxic coordinates. 3rd ed. San Diego: Academic Press, Inc.
39. Perez V, Gilaberte I, Faries D, Alvarez E, Artigas F (1997). Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 349:1594-1597.
40. Radley JJ, Jacobs BL (2002). 5HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Res 955:264-267.
41. Rampello L, Chiechio S, Nicoletti G, Alvano A, Vecchio I, Raffaele R, Malaguarnera M (2004). Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology 173:73-78.
42. Romero L, Hervas I, Artigas F (1996). The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic anti-depressants in rat brain. Neurosci Lett 219:123-126.
43. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805-809.
44. Seki T, Arai Y (1995). Age-related production of new granule cells in the adult dentate gyrus. Neuroreport 6:2479-2482.
45. Stump G, Durrer A, Klein AL, Lütolf S, Suter U, Taylor V (2002). Notch1 and its ligands delta-like and Jagged are expressed and active in distinct cell populations in the postnatal mouse brain. Mech Dev 114:153-159.
46. Tome MB, Isaac MT, Harte R, Holland C (1997). Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. Int Clin Psychopharmacol 12:81-89.
47. Wang L, Chopp M, Zhang RL, Zhang L, Letourneau Y, Feng YF, et al. (2009a). The Notch pathway mediates expansion of a progenitor pool and neuronal differentiation in adult neural progenitor cells after stroke. Neuroscience 158:1356-1363.
48. Wang SH, Zhang ZJ, Guo YJ, Teng GJ, Chen BA (2008). Hippocampal neurogenesis and behavioural studies on adult ischemic rat response to chronic mild stress. Behav Brain Res 189:9-16.
49. Wang SH, Zhang ZJ, Guo YJ, Zhou H, Teng GJ, Chen BA (2009b). Anhedonia and activity deficits in rats: impact of post-stroke depression. J Psychophar-macol 23:295-304.
50. Whitaker-Azmitia PM (1991). Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol Rev 43:553-561.
51. Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M (2000). Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 31:1829-1832.
52. Willner P, Muscat R, Papp M (1992). Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16:525-534.
53. Zanardi R, Artigas F, Franchini L, Sforzini L, Gasperini M, Smeraldi E, Perez J (1997). How long should pindolol be associated with paroxetine to improve the antidepressant response? J Clin Psychopharmacol 17:446-450.